Literature DB >> 17136757

Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.

C T Ong1, Y T Khoo, E K Tan, A Mukhopadhyay, D V Do, H C Han, I J Lim, T T Phan.   

Abstract

Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis during the wound healing process. As epithelial-mesenchymal interactions have been shown to regulate a plethora of genes in wound healing, we hypothesized that these interactions might have a role in modulating VEGF expression and angiogenesis. A two chamber co-culture model was used, wherein normal and keloid keratinocytes and fibroblasts were physically separated by membrane inserts while allowing cytokine diffusion. Cell lysates obtained from keratinocytes co-cultured with fibroblasts demonstrated increased expression of VEGF. An enzyme-linked immunosorbent assay (ELISA) showed significant increase in VEGF expression in co-culture conditioned media compared with controls. Additionally, the conditioned medium from keloid keratinocyte and fibroblast co-cultures increased proliferation and formation of complex three-dimensional capillary-like structures in human umbilical vein endothelial cells, emphasising the importance of epithelial-mesenchymal interactions in the angiogenic process. Immunostaining of keloid tissue localized VEGF in the basal layer of the epidermis and also demonstrated higher blood vessel density than normal skin. Keloid tissue extract also demonstrated increased expression of VEGF compared with normal skin. It is likely that epidermal VEGF exerts significant paracrine control over the dynamics and expression profile of underlying dermal fibroblasts. Addition of the inhibitors WP631, mitoxantrone, and Rapamycin to keloid keratinocyte and fibroblast co-cultures, downregulated secreted VEGF expression in a dose-dependent manner, suggesting therapeutic potential for these compounds in the treatment of keloid scars. Copyright (c) 2006 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17136757     DOI: 10.1002/path.2081

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

1.  Innovative therapies in the treatment of keloids and hypertrophic scars.

Authors:  Martha H Viera; Sadegh Amini; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-05

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Nicotinic acetylcholine receptor α7 subunit is time-dependently expressed in distinct cell types during skin wound healing in mice.

Authors:  Yan-Yan Fan; Tian-Shui Yu; Tao Wang; Wei-Wei Liu; Rui Zhao; Shu-Tao Zhang; Wen-Xiang Ma; Ji-Long Zheng; Da-Wei Guan
Journal:  Histochem Cell Biol       Date:  2011-03-10       Impact factor: 4.304

4.  Recombinant human endostatin reduces hypertrophic scar formation in rabbit ear model through down-regulation of VEGF and TIMP-1.

Authors:  Peng Wang; Li-Zhu Jiang; Bin Xue
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 5.  Endostatin in Renal and Cardiovascular Diseases.

Authors:  Mei Li; Zoran Popovic; Chang Chu; Bernhard K Krämer; Berthold Hocher
Journal:  Kidney Dis (Basel)       Date:  2021-09-09

Review 6.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

7.  Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.

Authors:  Tai-Lan Tuan; Paul Hwu; Wendy Ho; Peter Yiu; Richard Chang; Annette Wysocki; Paul D Benya
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.

Authors:  Yan Li; Julei Zhang; Wei Zhang; Yang Liu; Yuehua Li; Kejia Wang; Yijie Zhang; Chen Yang; Xiaoqiang Li; Jihong Shi; Linlin Su; Dahai Hu
Journal:  J Mol Histol       Date:  2017-09-07       Impact factor: 2.611

Review 9.  Vascular Endothelial Growth Factor and Cutaneous Scarring.

Authors:  Traci A Wilgus
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-11-06       Impact factor: 4.730

10.  Pirfenidone inhibits epithelial-mesenchymal transition in keloid keratinocytes.

Authors:  Latha Satish; Alexander Evdokiou; Eleni Geletu; Jennifer M Hahn; Dorothy M Supp
Journal:  Burns Trauma       Date:  2020-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.